Midcap outperforms Nifty, Sensex ranged; Pharma rebounds

Sun Pharma to acquire Ranbaxy in $4 billion all-stock dealSun Pharma to acquire Ranbaxy in $4 billion all-stock deal

Equity benchmarks remained rangebound in late morning deals as investors closely watch crude oil prices and corporate earnings.

The 30-share BSE Sensex was down 1.57 points at 33,369.19 and the 50-share NSE Nifty fell 7.90 points to 10,342.30 despite positive market breadth.

About 1,293 shares advanced against 1,034 declining shares on the BSE.

For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co

Facebook Twitter YouTube Pinterest Linkedin Google+

You may also like:

Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited' width= Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed' width=
Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed
Share Button

About the Author

Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300